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Objective: This study aims to determine the strength of relationship between pregnancy-associated
plasma protein A (PAPP-A) concentrations, using a Thai-speciﬁc reference range, and rates of idio-
pathic preterm delivery.
Materials and methods: A retrospective cohort study was conducted on consecutive singleton pregnan-
cies, undergoing ﬁrst-trimester screening for fetal Down syndrome, between January 2007 and July 2012,
at our network hospitals in the northern part of Thailand. The prospective database was assessed for the
records with complete outcome information, including PAPP-A concentrations, gestational age at de-
livery, medical and obstetric complications, and fetal and pregnancy outcomes. Pregnancies with po-
tential causes of preterm delivery were excluded. The recruited women were assigned to two groups; a
group with normal PAPP-A levels (10th percentile) and a group with low PAPP-A levels (<10th
percentile). The main outcome was the rate of idiopathic preterm births in the two groups.
Results: Of 6867 screened women, 3830 were available for analysis and 670 were excluded because of
potential confounders. Of the remaining 3160, 302 had low PAPP-A levels and 2858 had normal PAPP-A
levels. The rates of spontaneous preterm births at 36 weeks, 34 weeks, and 32 weeks of gestation
were signiﬁcantly higher in women with low PAPP-A levels (7.6% vs. 17.9%, 3.1% vs. 11.9%, and 2.2% vs.
11.9%, respectively), with a relative risk of 2.37, 3.79, and 5.41 for preterm birth, respectively.
Conclusion: A PAPP-A level of 10th percentile was signiﬁcantly associated with an increased risk for
idiopathic preterm birth. Therefore, pregnant womenwith low PAPP-A levels in the ﬁrst trimester should
be considered at a high risk of preterm delivery.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Preterm birth is the most common direct cause of neonatal
death, especially in developing countries. It accounts for 27% of
neonatal deaths worldwide, comprising over 1 million deaths
annually [1]. All attempts must be made to prevent this serious
event. Additionally, the rates of preterm birth are increasing. The
rate in our region, the northern part of Thailand, is as high as 15% of
live births. In the past, medical efforts focused on ameliorating theand Gynecology, Faculty of
Thailand.
@cmu.ac.th (S. Luewan).
bstetrics & Gynecology. Publishedconsequences of prematurity rather than preventing its occurrence.
This approach resulted in improved neonatal outcomes, but it re-
mains costly in terms of the suffering of both infants and their
families and the economic burden on society. Currently, primary
prevention of preterm birth is increasingly being emphasized.
Several strategies have been introduced, such as public education,
smoking cessation, or improved nutritional status. Widely accepted
strategies in the recent years may include progesterone adminis-
tration in cases of prior preterm birth, and current singleton
pregnancies with short cervical length or cervical cerclage in
selected cases [2]. Owing to the availability of effective strategies
for prevention of preterm birth, risk identiﬁcation of preterm birth
is even more essential. Identiﬁcation of risk factors for preterm
delivery early in pregnancy may provide an opportunity forby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1
Pregnancy-associated complications excluded from the analysis.a
Total (N ¼ 670)
Chronic hypertension 76 (2.0%)
Heart disease 19 (0.5%)
Prior preterm birth 120 (3.1%)
Placenta previa 49 (1.3%)
Pregestational DM 89 (2.3%)
Preeclampsia 154 (4.0%)
Smoking/alcohol 11 (0.3%)
Fetal growth restriction 122 (3.2%)
Other complicationsb 89 (2.3%)
DM ¼ diabetes mellitus.
a One patient might have more than one complication.
b Other medical or obstetric complications with theoretical risk of
preterm labor such as placental abruption, thyrotoxicosis, thalassemia
disease, etc.
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births occur in case of womenwith no risk factors, and the number
of effective interventions is limited. Since ﬁrst-trimester serum
marker screening for fetal Down syndrome has been used world-
wide, it has been shown that an unexplained low levels of
pregnancy-associated plasma protein A (PAPP-A), a component of
serum markers, is strongly related to preterm delivery and other
adverse outcomes of pregnancy [3,4]. First-trimester screening for
Down syndrome, PAPP-A, and beta-human chorionic gonadotropin
(b-hCG), is routinely offered in our geographical regions. Therefore,
it is possible that PAPP-A levels may help identify pregnant women
at a higher risk of preterm delivery. As already known, PAPP-A
concentrations in maternal serum vary depending on several fac-
tors, including maternal size and ethnicity, and each geographical
region should have its own reference ranges [5,6]. Moreover, in
most previous studies, other predisposing factors of preterm birth
were not strictly controlled. Therefore, we conducted this study to
determine the strength of relationship between PAPP-A concen-
trations using our own reference range [5] and rates of idiopathic
preterm delivery.
Patients and methods
A retrospective cohort study was conducted on consecutive
singleton pregnancies undergoing ﬁrst-trimester screening for
fetal Down syndrome between 11 weeks and 14 weeks of preg-
nancy, at our 32 network hospitals in the northern part of
Thailand. We have established a program for prenatal Down
syndrome screening and a prospective database since 2010. All
pregnant women attending antenatal care clinics at our network
hospitals have routinely been offered ﬁrst-trimester Down syn-
drome screening, regardless of maternal age. Baseline de-
mographic data of the women, including maternal age, parity,
maternal body weight, ethnic origin, smoking habits or illicit drug
use, as well as medical complications were assessed and recorded
in the protocol form at the time of blood sample collection. The
collected blood samples were immediately transferred to the
laboratory and were centrifuged for serum separation. The bio-
assays for PAPP-A and free b-hCG were performed in batches to
eliminate interassay variations, using a DELFIA Xpress system
(Perkin Elmer, Waltham, MA, USA). The absolute concentrations of
serum PAPP-A, and free b-hCG were converted to multiple of
medians (MoM) based on Thai gestation-speciﬁc medians and
weight correction [5]. A combined risk of 1:250 or greater was
considered as positive, and karyotyping would be offered.
The database of our fetal Down syndrome screening program
between 2010 and 2012 was assessed for the records that had
complete outcome information, including PAPP-A concentrations,
gestational age at delivery, medical and obstetric complications,
and fetal and pregnancy outcomes. The women were enrolled in
our screening program with written informed consent. Inclusion
criteria included the following: (1) Thai ethnicity; (2) singleton
pregnancies; (3) reliable gestational age based on the last men-
strual period and ultrasound examination for crownerump length
in the ﬁrst trimester, using real-time machines; (4) no history of
previous spontaneous preterm birth; and (5) no medical or ob-
stetric complications. Exclusion criteria were as follows: (1) late-
occurring pregnancy complications such as preeclampsia,
placental abruption, placenta previa, etc.; (2) fetal anomalies; (3)
fetal chromosomal abnormalities; (4) incomplete data, loss to
follow-up, or unavailability of pregnancy outcomes; and (5) pre-
term births indicated.
The recruited women were assigned to two groups: one group
with normal PAPP-A levels (10th percentile; equivalent to 0.53
MoM) and the other group with low PAPP-A levels (<10thpercentile). The main outcome was the rate of spontaneous pre-
term births in the two groups. Preterm births were classiﬁed into
three groups: birth before 37 complete weeks, 34 complete weeks,
and 32 complete weeks of gestation. This study was ethically
approved by the institute review boards.
Statistical analysis
The statistical analysis was performed using SPSS version 17.0
(SPSS, Chicago, IL, USA). Descriptive statistics were used to compare
baseline characteristics between the two groups, using Student t
tests for continuous variables and chi-square or Fisher's exact tests
for categorical variables. A p value of <0.05 was considered statis-
tically signiﬁcant. Relative risk for preterm birth for pregnancy with
a low PAPP-A level was calculated, as well as 95% conﬁdent interval.
A receivereoperator curve was also constructed to determine the
diagnostic performance of low PAPP-A levels in predicting preterm
birth.
Results
During the 3 years of study, the database search identiﬁed
6867 pregnant women with ﬁrst-trimester screening in the 34
network hospitals in the northern part of Thailand. However,
only 3830 had complete follow-ups with available fetal and
pregnancy outcomes. Most cases were excluded at this step
because of incomplete data of the neonatal or maternal status,
and some with no delivery at the time of analysis. After a thor-
ough review, 670 women were further excluded because of an
association with potential confounders for spontaneous or
intended preterm delivery, for example, prior preterm birth,
preeclampsia, severe fetal growth restriction, placenta previa,
placental abruption, smoking, and several medical and other
complications, as shown in Table 1. Of 670 excluded women, the
prevalence of preeclampsia in the group of low PAPP-A levels was
signiﬁcantly higher, 9.5% versus 3.4%. The remaining 3160
women were available for analysis. The baseline characteristics of
pregnant women between the group of normal PAPP-A levels and
that of low PAPP-A levels are demonstrated in Table 2. Medians of
corrected MoMs of PAPP-A among pregnancy with term birth
and preterm birth before 37 complete weeks, 34 complete weeks,
and <32 complete weeks of gestation were 1.39, 1.27, 0.97, and
0.80 MoM, respectively. The mean gestational age and mean
birth weight were signiﬁcantly lower in the group of low PAPP-A
levels, 38.1 weeks versus 36.3 weeks and 3043 g versus 2713 g,
respectively. Notably, maternal weight in the group of normal
PAPP-A levels was signiﬁcantly lower than that in women with
low PAPP-A levels, 53.4 kg versus 58.9 kg.
Table 2







Mean ± SD Mean ± SD
Maternal age (ye) 30.9 4.7 31.2 4.7 0.295
Gestational age (wk)
at delivery
38.1 2.6 36.3 6.2 <0.001
Gestational age (d)
at sampling date
86.7 6.1 86.1 5.9 0.054
Maternal weight (kg) 53.4 7.9 58.9 9.9 <0.001
Birth weight (g) 3043 547 2713 993 <0.001
PAPP-A ¼ pregnancy-associated plasma protein A; SD ¼ standard deviation.
Table 4
Accuracy of PAPP-A in predicting preterm birth (before 37 weeks of gestation), using
a cutoff of <10th percentile.
PAPP-A levels Preterm birth (n) Term birth (n) Total
Abnormal 54 248 302
Normal 216 2642 2858
Total 270 2890 3160
Sensitivity 20.0% (95% CI: 15.2%e24.8%).
Speciﬁcity 91.4% (95% CI: 90.4%e92.4%).
Positive predictive value 17.9% (95% CI: 13.6%e22.2%).
Negative predictive value 92.4% (95% CI: 89.5%e95.4%).
Accuracy 85.0% (95% CI: 84.1%e86.6%).
CI ¼ conﬁdence interval; PAPP-A ¼ pregnancy-associated plasma protein A.
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term birth and preterm birth before 37 complete weeks, 34 com-
plete weeks, and 32 complete weeks of gestation were 1.39, 1.27,
0.97, and 0.80 MoM, respectively. The main outcomes or rates of
spontaneous preterm birth, as classiﬁed in the three groups, were
signiﬁcantly higher in women with low PAPP-A levels with relative
risks of 2.37, 3.79, and 5.41 for preterm birth before 37 complete
weeks, 34 complete weeks, and 32 complete weeks of gestation,
respectively, as shown in Table 3. Accuracy of PAPP-A in predicting
preterm birth is presented in Table 4.
The receiver-operating characteristic curve had fairly predictive
performance of PAPP-A levels for preterm birth at  37 weeks of
gestation with an area under curve of 0.763 (at various points of
MoM), as shown in Figure 1.Figure 1. Predictive ability of a PAPP-A level of 10th percentile for preterm birth at
37 weeks of gestation (area under curve 0.763). PAPP-A ¼ pregnancy-associated
plasma protein A; ROC ¼ receivereoperator curve.Discussion
The results of this study demonstrated that the PAPP-A level, as
a component of ﬁrst-trimester serum marker screening, was an
independent predictor of preterm birth. The data of PAPP-A in
relation to preterm delivery in this study were consistent with the
observations in other studies in the Western population, as shown
in Table 5 [3,4,7e10]. However, unlike most previous studies, all
known potential confounding factors were excluded from analysis.
Therefore, the result was reﬂective of the direct association of low
PAPP-A levels on idiopathic preterm delivery. In spite of no obvious
precipitating factors of preterm birth, a PAPP-A level of <10th
percentile (0.53MoM in this study) had a relative risk of 2.4e5.4 for
preterm birth. Such a risk seems to be more pronounced compared
with that in other previous studies. This may possibly be associated
with racial factors since PAPP-A levels are deﬁnitely associated with
ethnicity [5,6].
PAPP-A was ﬁrst identiﬁed in 1974 [11]. It is a glycoprotein,
derived from the syncytiotrophoblast, which becomes detectable
within the maternal circulation soon after implantation [12]. PAPP-
A has a proteolytic cleavage action for insulin-like growth factor
binding protein (IGF-BP)-4 [13]. Thus, low PAPP-A levels are asso-
ciated with higher levels of IGF-BP-4, leading to lower levels of free
IGF. Since IGFs play a signiﬁcant role in the paracrine action in
controlling uptake of glucose and amino acids in trophoblasts, they
probably involve in trophoblast invasion of the deciduas [14e17].Table 3
Comparison of the rates of preterm birth prior to 37 weeks, 34 weeks, and 32 weeks of
Delivered before PAPP-A >10th percentile (N ¼ 2858) PAPP-A <10th perce
37 wk 216 (7.6%) 54 (17.9%)
34 wk 90 (3.1%) 36 (11.9%)
32 wk 63 (2.2%) 36 (11.9%)
CI ¼ conﬁdence interval; PAPP-A ¼ pregnancy-associated plasma protein A.Therefore, it is reasonable to presume that preterm labor or other
obstetric conditions associated with low PAPP-A levels are likely
associated with poor trophoblastic invasion or abnormal placen-
tation in early gestation, although the true mechanism is unclear.
Currently, ﬁrst-trimester screening with serum makers has
commonly been used for fetal Down syndrome screening in our
population, while nuchal translucency (NT) is usually not available.
Thereby, PAPP-A levels are available in a great number of pregnant
women in our country. Although the main purpose of using ﬁrst-
trimester serum makers is fetal Down syndrome screening, they
are informative and may probably be very helpful in predicting
preterm delivery. This information may be useful clinically, espe-
cially in areas of a high prevalence of preterm birth, similar to ourgestation between the groups of normal and low PAPP-A levels.
ntile (N ¼ 302) Total (N ¼ 3160) p Relative risk (95% CI)
270 (8.5%) <0.001 2.366 (1.799e3.110)
126 (4.0%) <0.001 3.785 (2.620e5.469)
99 (3.1%) <0.001 5.408 (3.654e8.003)
Table 5
Comparison of association between low PAPP-A levels and preterm births among various studies.
Population (n) Incidence of preterm birth (%) PAPP-A cutoff (percentile/MoM) Sensitivity (%) PPV OR/RR
Dane et al [9] 868 5th/0.35 N/A N/A 7
D'Antonio et al [8] 12,355 6.6 5th 14.0 19.1 3.71
Jelliffe-Pawlowski et al [10] (<30 wk) 76,588 6.2 5th N/A N/A 2.2
Goetzinger et al [4] (<35 wk) 2231 13.5 10th/0.59 N/A N/A 2.0
Brameld et al [7] 22,695 7.26 5th/0.4 8.74 16.73 2.24
Spencer et al [3] 50,902 6.1 5th/0.4 N/A N/A 1.92
This study 3160 8.5 10th/0.53 20.0 17.9 2.4
MoM ¼ multiple of medians; N/A ¼ not available; OR ¼ odds ratio; PAPP-A ¼ pregnancy-associated plasma protein A; RR ¼ relative risk; PPV = positive predictive value.
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are at a higher risk of preterm birth. Although, in the current
guidelines, preterm birth prevention in cases of low PAPP-A levels
are not recommended for progesterone prophylaxis or cervical
cerclage as indicated in cases of previous preterm birth or short
cervical length measured on transvaginal ultrasound [2], close
monitoring for early detection or cervical length measurement at
midgestation may be indicated in cases of unexplained low PAPP-A
levels. Nevertheless, clinical use of serum PAPP-A measurement as
a marker of an increased risk of preterm delivery should be studied
further. For example, the relationship between cervical length and
PAPP-A levels should be investigated. It is possible that pregnant
womenwith low PAPP-A levels and a short cervix may beneﬁt from
progesterone prophylaxis as in pregnancies with prior preterm
birth. Our results may serve as evidence for further studies on risk
identiﬁcation and prevention of spontaneous preterm delivery.
The strength of this study may include exclusion of all known
potential confounders of preterm birth, resulting in high reliability
of the conclusion. Limitations of this study may include a retro-
spective design leading to a large number of losses to follow-up and
cases with incomplete data. Additionally, other adverse outcomes
such as preeclampsia or fetal death, which have been reported to be
associated with low PAPP-A levels as well, were not evaluated. Of
such cases, preterm birth was theoretically more prevalent.
Therefore, considering all pregnant women, the prevalence of
preterm birth among those with low PAPP-A levels might have
been even more. However, the objective of our study was to assess
the relationship between idiopathic preterm birth and low PAPP-A
levels, not including intended preterm birth commonly indicated
by preeclampsia, etc.
In conclusion, a PAPP-A level of 10th percentile is signiﬁcantly
associatedwith an increased risk for idiopathic preterm birth. Unlike
other previous reports, this study excluded all known risk factors for
preterm birth, such as previous preterm births. Therefore, our results
could permit us to conclude that PAPP-A level is an independent risk
factor for preterm birth. This serves as strong evidence to warrant
clinicians to beware of preterm birth in cases of low PAPP-A levels
regardless of other risks of preterm birth. Accordingly, our results
may serve as evidence for further studies on risk identiﬁcation and
prevention of spontaneous preterm delivery.
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